Indicaton
AUP-55 is a Cell & Gene Therapy for local injection, for the treatment of ovarian cancer, peritoneal carcinomatosis, bladder cancer. AUP-55 consists of genetically engineered lactic acid bacteria including endogenous TLR2, TLR9, NOD2 agonists and producing human-interferon-alpha 2B and Interleukin-15-Sushi super agonist
